Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries GT Biopharma Inc (NQ: GTBP ) 2.990 +0.070 (+2.40%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about GT Biopharma Inc GT Biopharma Names Dr. Jeff Miller as Consulting Chief Medical Officer December 14, 2022 From GT Biopharma, Inc. Via GlobeNewswire GT Biopharma and Fate Therapeutics Present Preclinical Data Highlighting Novel Dual Antigen Targeting Approach For The Treatment of AML at ASH 2022 December 12, 2022 From GT Biopharma, Inc. Via GlobeNewswire GT Biopharma Presents Two Posters at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting November 10, 2022 From GT Biopharma, Inc. Via GlobeNewswire GT Biopharma to Present New Data on Novel Dual-Antigen Targeting Approach Against AML at Upcoming 2022 ASH Annual Meeting November 03, 2022 From GT Biopharma, Inc. Via GlobeNewswire GT Biopharma Reports Third Quarter Fiscal 2022 Financial Results and Business Update October 31, 2022 From GT Biopharma, Inc. Via GlobeNewswire GT Biopharma Announces Adjournment of Special Shareholders Meeting October 04, 2022 From GT Biopharma, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.